Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer

Medical and Pediatric Oncology

Volumn 37, Issue 1, 2001, Pages 4-9

  Hayakawa, H ^a   Komada, Y ^a   Hirayama, M ^a   Hori, H ^a   Ito, M ^a   Sakurai, M ^a  

^a MIE UNIVERSITY   (Japan)

Author keywords

Anthracycline; Cancer; Cardiotoxicity; Children; Natriuretic peptides

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DOXORUBICIN;

ADOLESCENT; ADULT; ARTICLE; CARDIOTOXICITY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION TEST; HUMAN; INFANT; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATRIAL NATRIURETIC FACTOR; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DOXORUBICIN; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HUMANS; INCIDENCE; INFANT; JAPAN; MALE; NATRIURETIC PEPTIDE, BRAIN; NEOPLASMS; STROKE VOLUME; TIME FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0034964104     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1155     Document Type: Article

References (19)

1. Cardiotoxicity 4-20 years after completing anthracycline therapy
2. Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: A series of 15 patients
3. Brain natriuretic peptide as a novel cardiac hormone in humans
4. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
5. Detection of left ventricular dysfunction after acute myocardial infarction: Comparison of clinical, echocardiographic, and neurohoumoral methods
6. Serum N-terminal atrial natriuretic peptide (NT-ANP) in the cardiac follow-up children with cancer
7. Stability of human atrial natriuretic peptide in blood samples
8. Plasma Concentrations of brain natriuretic peptide in patients with subarachnoid hemorrhage
9. Recommendations regarding quantitation in M-mode echocardiographic measurements
10. Assessment of diastolic function of the heart: Background and current applications of Doppler echocardiography. Part II. Clinical studies
11. Normal values for non-invasive estimation of left ventricular contractile state and afterload in children
12. Left ventricular diastolic function after anthracycline chemotherapy in childhood: Relation with systolic function, symptoms, and pathophysiology
13. Early and delayed clinical cardiotoxicity of doxorubicin
14. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
15. Preliminary study on behaviour of atrial natriuretic factor in anthracycline-related cardiac toxicity
16. Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects
17. Alterations in left ventricular diastolic function with Doxorubicin therapy
18. Review of tests for monitoring doxorubicin induced cardiomyopathy
19. Left ventricular diastolic filling patterns associated with anthracycline induced myocardial damage: A Prospective study